Generic version of sotorazeb: a new affordable treatment option
Sotorasib (Sotorasib), an anticancer drug used to treat non-small cell lung cancer, sold under the trade names Lumakras and Lumykras, targets a specific mutation, G12C, in the protein K-Ras encoded by the gene KRAS, which is associated with many forms of cancer. Sotoracib is an inhibitor of the RAS GTPase family and is the first targeted therapy approved for the treatment of patients with tumors with KRAS mutations, which account for approximately 25% of mutations in non-small cell lung cancer.
Genetic changes in the KRAS gene produce an altered protein that leads to uncontrolled growth of cancer cells. The active substance in sotorasib attaches to this altered protein in cancer cells. This prevents the protein from working, interrupting the chemical messages that cancer cells need to grow and spread, and also promotes processes that lead to cancer cell death.
The price of the original drug Sotorasibu is very expensive. The specification120mg*240 tablets of the drug listed in other regions (original drug in Hong Kong and Europe) is as high as RMB 40,000 to RMB 80,000. Many patients have long treatment cycles. For some families, the price of the original drug will be unaffordable. The launch of the generic version of sotorasibu has brought hope to patients. These generic drugs are basically the same as the original drugs in terms of ingredients, but their prices are quite different. Take Lucius Pharmaceutical Factory in Laos as an example. The price of the 120 mg * 56 tablets of sotoraxibu generic medicine they produce is only more than 1,000 yuan, which is far lower than the price of the original medicine. Similarly, the price of Daxiong Pharmaceutical's generic drugs is only about 2,000 yuan. Although it has increased slightly, it is still a world of difference compared to the original drugs.
The advent of generic sotolaxib not only provides patients with an affordable treatment option, but also gives them hope. These generic drugs provide more patients with the opportunity to receive treatment and regain their health at affordable prices. Their emergence has undoubtedly brought good news to patients who cannot afford the high cost of medication due to financial reasons. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)